Repligen to Report Fourth Quarter and Full Year 2024 Financial Results

Rhea-AI Summary

Repligen (NASDAQ:RGEN) has announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 20, 2025, before market opening. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss business updates and financial results for the three- and twelve-month periods ended December 31, 2024.

The conference call will be available via toll-free numbers for domestic and international callers, and a webcast will be accessible through the company's Investor Relations website. Both the call and webcast will be archived for future access, with replay numbers provided for U.S., Canadian, and international callers using passcode 6188777.

News Market Reaction – RGEN

-2.84%

1 alert

-2.84% News Effect

On the day this news was published, RGEN declined 2.84%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Webcast and Conference Call to Be Held Thursday, February 20, 2025, at 8:30 a.m. ET

WALTHAM, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2024 financial results on Thursday, February 20, 2025. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. ET to discuss business updates and financial results for the three- and twelve- month reporting periods ended December 31, 2024.

The conference call will be accessible by dialing toll-free (844) 274-3999 for domestic callers and (412) 317-5607 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations section of the Company’s website. Both the conference call and webcast will be archived for a period of time following the live event. The replay dial-in numbers are (877) 344-7529 for callers in the U.S., (855) 669-9658 for callers in Canada and (412) 317-0088 for international callers. Replay listeners must provide the passcode 6188777.  

About Repligen Corporation

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the our company see our website at www.repligen.com, and follow us on LinkedIn.

This press release may contain forward-looking statements within the meaning of the federal securities laws. Investors are cautioned that statements in this press release which are not strictly historical statements including, without limitation, statements identified by words like “believe,” “expect,” “may,” “will,” “should,” “seek,” or “could” and similar expressions, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including risks discussed from time to time in our filings with the Securities and Exchange Commission. We expressly disclaim any responsibility to update any forward-looking statements, except as required by law.

Repligen Contact:
Sondra S. Newman
VP, Global Head of Investor Relations
(781) 419-1881
investors@repligen.com

FAQ

When will Repligen (RGEN) report Q4 2024 earnings?

Repligen will report its Q4 2024 earnings on Thursday, February 20, 2025, before the market opens.

What time is Repligen's (RGEN) Q4 2024 earnings call?

Repligen's Q4 2024 earnings conference call is scheduled for 8:30 a.m. ET on Thursday, February 20, 2025.

How can investors access Repligen's (RGEN) Q4 2024 earnings call?

Investors can access the call by dialing (844) 274-3999 (US) or (412) 317-5607 (international), or via webcast through Repligen's Investor Relations website.

What is the replay passcode for Repligen's (RGEN) Q4 2024 earnings call?

The replay passcode for Repligen's Q4 2024 earnings call is 6188777.